- Home
- About Us
- Products
- Our Capabilities
- Services
- Contract Development and Manufacturing Organisation {CDMO)
- Contract Manufacturing (CMO]
- Contract Research (CRO)
- Custom Synthesis / Third— Party Manufacturing
- DMF Preparation
- Formulation Research & Development (FR&D)
- Global Marketing Representation
- Market Research & Business Intelligence
- Quality Control (QC) Auditing
- Strategic Marketing
- Supply Chain Management
- Technology Transfer & Scale Up
- Business Partners
- Contact Us
Daclatasvir Di Hydrochloride
CAS NO: 1009119-65-6
THERAPEUTIC CATEGORY: Hepatitis C
